Jessica Toms
About Jessica Toms
Jessica Toms is the Clinical Development Lead for New Indications in Immunology Clinical Development at Bristol Myers Squibb, with extensive experience in medical affairs and clinical development across various pharmaceutical companies.
Current Role at Bristol Myers Squibb
Jessica Toms is currently serving as the Clinical Development Lead for New Indications, Immunology Clinical Development at Bristol Myers Squibb. Based in Princeton Pike, New Jersey, she is responsible for leading clinical development efforts specifically in the field of immunology. Her role involves strategizing and overseeing clinical trials to explore new therapeutic indications.
Previous Roles in Pharmaceutical Industry
Prior to her current role, Jessica Toms held notable positions at several pharmaceutical companies. She worked as the Director, Clinical Trial Lead for Immunology Clinical Development at Bristol Myers Squibb from 2018 to 2020. Before that, she served as the Head of Medical Affairs - IBD at Takeda Pharmaceuticals in the UK. Toms also filled roles at Celgene as a Senior Medical Affairs Advisor in Inflammation & Immunology and at Sanofi Pasteur MSD, where she was a Senior Medical Affairs Manager and Medical Affairs Manager.
Academic and Clinical Training
Jessica Toms received her Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Oxford, where she studied from 2004 to 2008. She also holds a Master of Science (MSc) in Control of Infectious Disease from the London School of Hygiene and Tropical Medicine, University of London. Toms attained her undergraduate degree, a BA in Human Sciences, from the University of Oxford.
Clinical and Academic Experience
Jessica Toms has a background in both clinical practice and academia. She worked as an Academic Clinical Fellow in Public Health at the University of Oxford and completed her Core Medical Training at Oxford University Hospital NHS Trust. Additional early career roles included positions as a Foundation Year Doctor at Ealing Hospital Trust and Central Middlesex Hospital in London. These experiences grounded her in clinical medicine and public health initiatives.
Experience in Immunology Clinical Development
Jessica Toms has substantial experience in immunology clinical development, demonstrated by her senior roles at Bristol Myers Squibb and Celgene. At Bristol Myers Squibb, she notably led the clinical development of new indications in dermatology for the TYK2 inhibitor program. Her professional trajectory underscores a focused expertise in the field of immunology.